Susquehanna Fundamental Investments, LLC Protagonist Therapeutics, Inc Transaction History

Susquehanna Fundamental Investments, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$23.34 - $36.08 $432,350 - $668,345	-18,524 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$17.63 - $37.1 $97,123 - $204,383	5,509 Added 42.33%	18,524 $634,000
Q3 2021 Nov 15, 2021	SELL	$12.95 - $49.69 $279,784 - $1.07 Million	-21,605 Reduced 62.41%	13,015 $231,000
Q2 2021 Aug 11, 2021	SELL	$25.57 - $44.88 $332,410 - $583,440	-13,000 Reduced 27.3%	34,620 $1.55 Million
Q1 2021 May 17, 2021	BUY	$19.02 - $31.15 $120,187 - $196,836	6,319 Added 15.3%	47,620 $1.23 Million
Q4 2020 Feb 16, 2021	SELL	$18.49 - $25.13 $1,830 - $2,487	-99 Reduced 0.24%	41,301 $833,000
Q3 2020 Nov 16, 2020	BUY	$15.19 - $22.4 $325,066 - $479,359	21,400 Added 107.0%	41,400 $809,000
Q2 2020 Aug 14, 2020	BUY	$6.19 - $18.84 $123,800 - $376,800	20,000 New	20,000 $353,000

247

56.4M

76.3K

114K

Ticker PTGX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 49,084,100
Market Cap $2B
Description
Protagonist Therapeutics, Inc., a biopharmaceutical company, discovers and develops peptide-based therapeutic drugs to address hematology and blood disorders, and inflammatory and immunomodulatory diseases. It is developing rusfertide (PTG-300), an injectable hepcidin mimetic that is in Phase II clinical trials for the treatment of patients with...

Get notified when there are updates to the investment portfolio of Susquehanna Fundamental Investments, LLC, based on Form 13F filings with the SEC.

Stay updated on Susquehanna Fundamental Investments, LLC with notifications on news.